Effective Competitive Intelligence: A ``How-To`` Guide for Life Science Companies
Often what separates successful marketing from bad is good competitive intelligence. This is true in life sciences as much as other industries. Many companies approach CI in a way that is unplanned, indirect and harmful to their business. But how does one know if they are conducting their company's CI in the best way?
If you are trying to determine how to use competitive intelligence better, if you are attempting to judge your efforts compared to companies that have been successful, and if you want to know what computer resources might assist you, this guide can help. If you want to get more attention for CI in your organization, and develop a professional and worthwhile approach, this guide is the most useful, current and relevant published on the subject.
Prepared by Dr. Laura Ruth, PhD and the experts at Fuld & Company, jointly published with Kalorama Information, a premier life sciences market research publisher, can assist executives in the life science tasked with implementing competitive intelligence activities.
The utility and power of competitive intelligence for improving decision-making for strategy, operations, and tactical applications comes from knowing what CI can and cannot do and how it fits into the spectrum of widely used market analysis techniques. Data from a 2007 CI benchmarking survey from Fuld & Company, ‘From Stick Fetchers to World Class™’ indicates that CI is part of many pharmaceutical and biotechnology companies. The pharmaceutical and biotech companies are spending anywhere from less than $100,000 dollars to more than $2 million dollars. The years of experience the information in this guide represents is intended for anyone in the life sciences using CI, such as brand managers, R&D managers, regulatory affairs, or investor relations, who is either learning about CI for the first time or building on information they already know. Highlights:
RELATED REPORTS
It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products.Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, ...
Industries : Pharmaceutical
The period 2008-2023 will see a vaccine “boost”. There will be a new resurgence in the sales and utilisation of vaccines. Are you prepared for this? You should be. During this period, vaccines will be one of the fastest growing segments of the pharmaceutical market. Vaccine revenues will increas ...
Industries : Pharmaceutical
The global pharmaceutical market is expected to earn over a trillion dollar in revenues by 2012 and according to ````Global Pharmaceutical Market Forecast to 2012”, our new research report, the market will witness a number of changes impacting its course of growth. These include the shift of growt ...
Industries : Pharmaceutical
“Global Vaccine Market Forecast to 2012”, our new research report, states that vaccines, which were earlier thought as a low margin, low growth industry, have emerged as one of the most lucrative segments in the pharmaceutical industry. With a projected CAGR growth of over 16% in the next five y ...
Industries : Pharmaceutical
This report contains: An overview of the in-vitro toxicology testing market, explaining basic principles and practices, definitions, classes of tests, and the different types of toxicology; A technical overview that describes toxicology testing strategies, the various toxicology categories, and alte ...
Industries : Pharmaceutical
One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of people with chronic pain are less able or unable to exercise, sleep normally, perform household chores, attend ...
Industries : Pharmaceutical
Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world. Several leading Indian pharmaceutical companies have applied themselves to the challenge of entering Weste ...
Industries : Pharmaceutical
Evidence-based medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments. The term can be taken to cover a wide variety of recommendations and guidelines, as well ...
Industries : Pharmaceutical
Objectives and ScopeThe intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin’s ...
Industries : Pharmaceutical
The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical comp ...
Industries : Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved